Utsav Aiya, MD

Mitigating the spread of a virus as infectious as SARS-CoV-2, the virus which causes COVID-19, requires having ample and accurate diagnostic tests available. However, in the United States community transmission began to occur before adequate testing measures could be implemented.

AHA/ASA Stroke Council leadership published temporary emergency guidance for stroke management in the midst of COVID-19.

The promotion of arrhythmias in myocytes by mesenchymal stromal cells isolated from failing human hearts, which were found to produce high levels of interleukin-6 (IL-6), was abated in the presence of anti-IL-6 monoclonal antibodies.

Patients admitted to the hospital for myocardial infarction with a known diagnosis of obstructive sleep apnea were found to have improved in-hospital mortality.